Symposium Day 1 (30 July 2026)
30 July 2026 (Thu) | 08:00 - 16:30
Programme
30 Jul | 08:00 - 09:00
Registration and Breakfast
30 Jul | 09:00 - 09:10
Welcome & Introduction
30 Jul | 09:10 - 09:25
Guest of Honour - Opening Address
30 Jul | 09:25 - 09:45
"Strengthening Singapore’s Clinical Trials Ecosystem: Innovation, Inclusion and Impact"
Chief Executive Officer
Consortium for Clinical Research and Innovation, Singapore (CRIS)
30 Jul | 09:45 - 10:15
Keynote Speech
Instructor in Medicine
Duke University
Former U.S. FDA Commissioner
shaping global regulatory policy
shaping global regulatory policy
30 Jul | 10:15 - 10:30
MOU Signing Ceremony
30 Jul | 10:30 - 11:30
Plenary Panel
“Defining New Regulatory Paradigms for a Fast Changing World”
As scientific innovation accelerates—from AI-enabled drug discovery and decentralized trials to cell and gene therapies—the traditional boundaries of regulation are being fundamentally tested. Regulatory agencies worldwide are increasingly called upon not only to safeguard safety and efficacy, but also to enable timely access, foster innovation, and respond to evolving healthcare needs.This high-level plenary brings together global regulatory experts including Dr Robert Califf, Ms Emer Cooke, Adj A/Prof (Dr) Raymond Chua, and Prof John Lim to explore how regulatory frameworks must evolve in a rapidly changing world.
Chief Executive Officer, Health Sciences Authority (HSA)
Deputy Director-General of Health (Health Regulation), Ministry of Health (Singapore)
Professor & Executive Director, Centre of Regulatory Excellence (CoRE), Duke-NUS Medical School
Policy Core Lead, SingHealth Duke-NUS Global Health Institute
Senior Advisor, Ministry of Health, Singapore
(Moderator)
30 Jul | 11:30 - 13:00
Lunch & Networking
30 Jul | 12:00 - 13:00
Lunch Track
Sharing Session by HSA - GCP E6 Updates
Stay current with the latest developments in Good Clinical Practice guidelines as the Health Sciences Authority shares important updates to ICH E6. Join the session to gain clarity on regulatory expectations and understand key changes of the guideline.
Regulatory Consultant, Innovation Office & Clinical Trials Branch
Health Products Regulation Group, Health Sciences Authority
30 Jul | 13:00 - 14:30
Track 1: Trials That Matter
“Aligning Clinical Research with Health System and Societal Needs?”
Clinical research bridges the gap between scientific inquiry and real-world health system needs. This session focuses on designing trials that generate evidence relevant to health needs and policy requirements. Gain understanding of conducting research that delivers tangible benefits to patients and health systems.
30 Jul | 13:00 - 14:30
Track 2: From Data to Decision
“Real-World Data as a Core Pillar of Modern Clinical Trials”
As clinical research evolves to meet the demands of faster innovation, more inclusive participation, and real-world impact, real-world data (RWD) and real-world evidence (RWE) are emerging as critical enablers across the clinical trial continuum. RWE is increasingly shaping how trials are designed, conducted, and translated into meaningful healthcare decisions. This session explores how RWD can be transformed into decision-grade evidence to support regulatory, clinical and policy outcomes.
Director, Real‑World Study and Application Centre (RWSAC)
Greater Bay Area International Clinical Trial Institute (GBAICTI), Hong Kong
Associate Professor
University of Tennessee Health Science Center College of Pharmacy
30 Jul | 13:00 - 14:30
Track A: Catalyzing Innovation and Equity
“The Strategic Role of Philanthropy in Advancing Clinical Trials”
The role of philanthropy in clinical research is evolving from traditional funding to strategic partnership that addresses research gaps and promotes treatment equity. Acquire insights into harnessing philanthropic resources to accelerate innovation and expand equitable access to clinical advances.
30 Jul | 14:30 - 15:00
Tea Break
30 Jul | 15:00 - 16:30
Track 3: Innovations in Trial Design & Methodology
“Pragmatic & Real-World Evidence Studies”
Traditional clinical trial methodologies are evolving to better reflect real-world clinical practice and patient experiences. This session focuses on how pragmatic trial designs and real-world evidence studies are creating more meaningful connections between research findings and clinical practice.
30 Jul | 15:00 - 16:30
Track 4: Managing Global / Regional Trial Networks
“Operational Excellence & Ecosystem Partnerships”
Managing clinical trials across multiple regions demands sophisticated operational frameworks and strategic collaborative relationships. Gain strategic insights into optimising network performance, enhancing trial efficiency, and leveraging collaborative partnerships to deliver high-quality clinical research across global sites.
Program Director, Duke-NUS Medical School, Singapore
Senior Consultant Surgeon, National Cancer Centre Singapore
Group Director of Partnerships and Innovation
National University Health System (NUHS)
(Moderator)
30 Jul | 15:00 - 16:30
Track B: Talent Development – Building a Future-Ready Clinical Research Workforce
“Leadership Development in Clinical Research: Creating the Next Generation of PIs and Trial Managers”
The future of clinical research depends on cultivating skilled leaders who can navigate complex technological and methodological changes. Gain insights into building robust talent pipelines, fostering leadership capabilities, and creating sustainable workforce development initiatives.
Manager – Research Programs and Pipeline
Australia New Zealand Gynaecological Oncology Group (ANZGOG)
30 Jul | 16:30
End of Day 1
*Please note that the programme may be subject to change without prior notice.
Tracks 1-10 will comprise of a 45-min presentation by speakers followed by 45-min panel discussion.